C12N 2770/28022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/28022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 10 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 10
- Published applications
- 8
- Assignees
- 7
- Inventors
- 16
- Latest grant
- 30 May 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 2 |
| 2004 | 2 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 1 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Cattle reproductive disease vaccines30 May 2017US 9,662,384 B2Zoetis Services LLC
- Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E30 Nov 2010US 7,842,298 B2Virginia Tech Intellectual Properties, Inc.
- Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E1 Sep 2009US 7,582,303 B2Virginia Tech Intellectual Properties, Inc.
- Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E28 Feb 2006US 7,005,130 B2Virginia Tech Intellectual Properties, Inc.
- Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines16 Mar 2004US 6,706,873 B1The United States of America as represented by the Department of Health and Human Services
- Cattle reproductive disease vaccines23 May 2013US 2013/0129779 A1
- Cattle Reproductive Disease Vaccines21 Oct 2010US 2010/0266629 A1Pfizer Inc.
- Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e11 Feb 2010US 2010/0034845 A1Virginia Tech Intellectual Properties, Inc.
- Cattle reproductive disease vaccines27 Dec 2007US 2007/0298053 A1Pfizer Inc.
- Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E17 Nov 2005US 2005/0255461 A1Virginia Tech Intellectual Properties, Inc.
Most cited
By later US patents
- Hepatitis E virus ORF Z peptides12US 5,770,689 AGenelabs Technologies, Inc. · 1998
- Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines8US 6,287,759 B1The United States of America as represented by the Department of Health and Human Services · 2001
- Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E2US 7,005,130 B2Virginia Tech Intellectual Properties, Inc. · 2006
- Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines1US 6,207,416 B1The United States of America as represented by the Department of Health and Human Services · 2001
- Hepatitis E virus vaccine and method1US 6,455,492 B1Genelabs Technologies, Inc. · 2002